Review decisions

Showing 130 results of 290 total
Summary Safety Review - Omnipod Insulin Management System - Assessing the potential risk of malfunctions with the device
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00195
Issued / Original Publication Date: 2018-03-21
Summary Safety Review - Halaven (eribulin mesylate) - Assessing the potential Risk of severe skin side effects
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00194
Issued / Original Publication Date: 2018-03-12
Summary Safety Review - Clozapine - Assessing the effectiveness of monitoring for low numbers of white blood cells
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00192
Issued / Original Publication Date: 2018-03-09
Updated Date: 2018-07-26
Summary Safety Review - SurgiWrap Adhesion Barrier Film - Assessing the potential risk of foreign body reactions that mimic local re-appearance of cancer
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00193
Issued / Original Publication Date: 2018-03-09
Summary Safety Review - Ophthalmic Viscosurgical Devices - Assessing the potential risk of inflammation of the front part of the eye (Toxic Anterior Segment Syndrome)
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00191
Issued / Original Publication Date: 2018-03-02
Summary Safety Review - Ruxolitinib - Assessing the potential risk of liver injury
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00190
Issued / Original Publication Date: 2018-02-26
Summary Safety Review - SGLT2 inhibitors - Assessing the potential risk of a rare brain condition (posterior reversible encephalopathy syndrome) in patients who have developed high levels of acids in the blood (diabetic ketoacidosis)
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00189
Issued / Original Publication Date: 2018-02-08
Summary Safety Review - Dipeptidylpeptidase-4 inhibitors - Assessing the potential risk of a skin reaction (bullous pemphigoid)
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00188
Issued / Original Publication Date: 2018-01-25
Summary Safety Review - AVONEX (interferon beta-1a) - Assessing the Potential Risk of an Inflammatory Disease that Affects One or More Organs (Sarcoidosis)
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00187
Issued / Original Publication Date: 2018-01-08
Summary Safety Review - Barbed (knotless) sutures - Assessing the potential risk of intestine blockage (small bowel obstruction)
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00186
Issued / Original Publication Date: 2018-01-05

Displaying 121 - 130 of 290 | Page 13 of 29
Report a problem or mistake on this page
Please select all that apply:
Date modified: